Simon Kimuda is a Ugandan postdoc supported by the Crick African Network. He studied Biomedical Lab Science for his first degree and obtained his MSc and PhD degrees in immunology from Makerere University, Uganda. His research is focused on tuberculosis (TB), an infectious disease that is common in his home country.
Simon is working closely with the Schumann lab to characterise immune responses against mycobacterial glycans in children that are able to resist TB infection despite being exposed to the disease to advance the development of new anti-TB vaccines. He is fascinated by the glycolipid, liporarabinomannan, mainly because of its critical role in immunomodulation and enhancement of the virulence of Mycobacterium tuberculosis.
When he is not working, he enjoys cycling and listening to music. He also loves good food!